Haisco Pharmaceutical Group

Haisco Pharmaceutical Group

Haisco Pharmaceutical Group

Latest investments Show all
$15,000,000
Venture capital (Series D)
Regentis Biomaterials Ltd.
$10,000,000
Venture capital
EndoSpan
Team Size
1–10
Employees
Past year's investments

Haisco Pharmaceutical Group participated in fewer than 3 rounds over the past year

Latest rounds
  • Regentis Biomaterials Ltd.: Venture capital (Series D) ($15M)
  • EndoSpan: Venture capital ($10M)
  • M.S.T - Medical Surgery Technologies Ltd.: Venture capital (Series C) ($12.5M)
Main Co-investors